Dermatol. praxi. 2016;10(3):136-140 | DOI: 10.36290/der.2016.031

Granulomatous rosacea

MUDr. Zuzana Nevoralová, Ph.D.1, doc. MUDr. Lumír Poch, CSc.2
1 Kožní oddělení, Nemocnice Jihlava
2 Bioptická laboratoř Plzeň

Granulomatous rosacea is a rare form of rosacea. It is characterized by numerous brown-red papules or little nodules on a diffusely reddened, thickened skin localized mostly on the face. Epitheloid granulomas of the noncaseating type with foreign-body type giant cells are the histopathological equivalent of these lesions. Multifactorial etiology has been suggested. The disease requires special care, treatment with oral antibiotics or isotretinoin is necessary in most cases. A case of granulomatous rosacea is presented. A 44-year-old woman suffered from red papules on the forehead and the left cheek. A therapy using peroral isotretinoin had a positive effect. No side effects of the therapy were found, and a complete healing of the papules was achieved. The patient is still being followed up; she is still undergoing a maintenance therapy and following all the rosacea protection measures.

Keywords: granulomatous rosacea, lupoid, granuloma, peroral isotretinoin

Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z, Poch L. Granulomatous rosacea. Dermatol. praxi. 2016;10(3):136-140. doi: 10.36290/der.2016.031.
Download citation

References

  1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea. Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002? 46(4): 584-587. Go to original source... Go to PubMed...
  2. Schauber J, Horney B, Steinhoff M. Aktuelles Verständnis Der Pathophysiologie der Rosacea. Hautarzt 2013? 64: 481-488. Go to original source... Go to PubMed...
  3. Fimmel S, Abdel-Naser MB, Kutzner H, Kligman AM, Zoubolis CC. New aspects of the pathogenesis of rosacea. Drug Discovery Today 2008? 5: e103-e111. Go to original source...
  4. Jansen T. Rosacea. In: Plewig G, Kligman AM. Acne and Rosacea, 3rd ed, eds: Berlin: Springer, 2000? 456-501.
  5. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J EurAcad Dermatol Venereol 2010; 24: 565-571. Go to original source... Go to PubMed...
  6. Lewandowsky F. Über Rosacea-ähnliche Tuberkulide des Gesichtes. Corr Bl Schweitz Ärtze 1917? 47: 1280-1282.
  7. Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991? 25: 1038-1043. Go to original source... Go to PubMed...
  8. Van Ketel WG. Does the rosacea-like tuberkulid exist? Arch Dermatol 1959? 79: 723. Go to original source...
  9. Mullanax MG, Kierland RR. Granulomatous Rosacea. Arch Dermatol 1970? 10: 206-211. Go to original source...
  10. Lehman PM. Rosacea: Epidemiology, Pathogenesis, Clinical Presentation and Treatment. Dtsch Arztebl 2007? 104: A1741-A1746.
  11. Grunwald MH, Avinoach I, Halevy S. Granulomatous rosacea associated with Demodex folliculorum. Int J Dermatol 1992? 31: 718-719. Go to original source... Go to PubMed...
  12. Plewig G. Lupoid rosacea. In: Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Dermatology, 3rd ed, eds: Springer-Verlag Berlin-Heidelberg-New York, 2009? 1011.
  13. Schöfer H. Topische Therapie der Rosacea. Hautarzt 2013? 64: 494-499. Go to original source... Go to PubMed...
  14. Fallen RS, Gooderham M. Rosacea: up-date on management and emerging herapies.Skin Therapy Left 2012? 17: 1-4.
  15. Vanstreels L, Megahed N. Lupoide Rosazea als Sonderform der Rosazea. Hautarzt 2013? 64: 886-888 Go to original source... Go to PubMed...
  16. Thielitz A, Gollnick H. Rosazea. Systemische Therapie mit Retinoiden. Hautarzt 2011? 62: 820-827. Go to original source... Go to PubMed...
  17. Neto PBT, Lima JB, Silva ACO, Rocha KBF, Nunes JCS. Granulomatous rosacea: case report-a therapeutic focus. An Bras Dermatol 2006? 81: S320-S323. Go to original source...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.